← Back to companies
CHO Plus
Biotechnology2 open
12+ employees
CHO Plus is creating regulatory compliant genetically engineered mammalian cells to be used by biopharmaceutical companies for therapeutic protein manufacturing. Early proof of concept experiments demonstrate CHO Plus cells to be 4.5-fold more productive than parent cells in model system. The CHO Plus approach includes patented methods for genetically engineering mammalian cells; proprietary and patented targeted transfection technology; and efficient clone screening technology.
Open Positions at CHO Plus (2 Jobs)
Ready to start your space career at CHO Plus?
